Clinical Trial Update: Intestinal Microbiota Transplantation, Radiochemotherapy and Sintilimab in Localized Advanced Colon Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating intestinal microbiota transplantation, radiochemotherapy, and sintilimab for localized advanced rectal adenocarcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Advanced Rectal Adenocarcinoma

Drugs mentioned

• Sintilimab (Tyvyt) (sintilimab)

Snippet

Sponsor: First Affiliated Hospital of Ningbo University | Conditions: Localized Advanced Rectal Adenocarcinoma | Phase 4 | Status: ENROLLING_BY_INVITATION